H-1B sponsorship profile: Novo Nordisk Pharmaceutical Industries, LP. Across U.S. Department of Labor LCA disclosures, Novo Nordisk Pharmaceutical Industries, LP filed 16 Labor Condition Applications covering 16 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (16 certified of 16 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Novo Nordisk Pharmaceutical Industries, LP’s H-1B petitions range from $82,000 at the low end to $162,707 at the high end, with a petition-weighted average of $122,943. That range reflects the mix of occupations the company sponsors, led by QA Area Specialist IV (2 petitions at $125,021 avg), followed by Validation Area Specialist III - Virginia and Validation Area Specialist - Site Capacity. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Novo Nordisk Pharmaceutical Industries, LP is headquartered in Clayton, NC under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NC, VA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Novo Nordisk Pharmaceutical Industries, LP ranks. By H-1B petition volume, Novo Nordisk Pharmaceutical Industries, LP is #11,950 of 119,880 employers nationally and #333 of 2,377 employers headquartered in NC. Both ranks are computed live from the same underlying petition counts, not a separate estimate.